C12N 2015/8581
Animal models for infectious diseases
Official title: {Animal models for infectious diseases, e.g. AIDS}
C12N2015/8581 (Animal models for infectious diseases) appears on 5 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 10
- Assignees
- 10
- Inventors
- 29
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 3 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Kit for breeding a TGEV infection resistant pig and use thereof13 May 2025US 12,295,355 B2Agsino Gensources Co., Ltd.
- Recombinant Orf virus vector29 Mar 2022US 11,286,500 B2Eberhard Karls Universität Tübingen Medizinische Fakultät
- Urokinase-type plasminogen activator transgenic mouse6 Jul 2021US 11,051,496 B2Chugai Seiyaku Kabushiki Kaisha
- Methods and compositions for modulating AAV infection28 Apr 2020US 10,633,662 B2Oregon Health & Science University
- Urokinase-type plasminogen activator transgenic mouse1 May 2018US 9,955,675 B2Chugai Seiyaku Kabushiki Kaisha
- Full-length human ace2 mouse model susceptible to emerging coronaviruses26 Dec 2024US 2024/0423176 A1
- Kit for breeding a tgev infection resistant pig and use thereof28 Nov 2024US 2024/0389561 A1Agsino Gensources Co., Ltd.
- Humanized mouse models for study of covid-1916 Mar 2023US 2023/0080265 A1
- Recombinant orf virus vector30 Jun 2022US 2022/0204992 A1Eberhard Karls Universität Tübingen Medizinische Fakultät
- Method for Producing Virus-Infected Cell Line and Animal Model14 Apr 2022US 2022/0112515 A1Industry-Academic Cooperation Foundation, Yonsei University
Most cited
By later US patents